Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer - Concepedia

Concepedia

Publication | Open Access

Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer

DOI Full Paper Access

41

Citations

25

References

2020

Year

Elisabetta Zulato, Ilaria Attili, Alberto Pavan, Giorgia Nardo, Paola Del Bianco, Andrea Boscolo Bragadin, Martina Verza, Lorenza Pasqualini, Giulia Pasello, Matteo Fassan,

British Journal of Cancer

Abstract

Longitudinal analysis of plasma KRAS mutations correlated with outcome: its early assessment during treatment has great potentialities for monitoring treatment outcome in NSCLC patients.

References

	Year	Citations

Page 1